Institution Profiling / Case File

Neuralink conducts second brain chip implant trial

Neuralink conducts second brain chip implant trial is tracked as a internet infrastructure institution within the internet infrastructure ecosystem.

Neuralink conducts second brain chip implant trial

Sources

Public references used for this article.

External references will appear here after editorial citation review.

CategoryInstitution

Neuralink conducts second brain chip implant trial is tracked as a internet infrastructure institution within the internet infrastructure ecosystem.

RegionGlobal

Neuralink conducts second brain chip implant trial has public-source relevance to network operations, governance, dependency mapping, or market structure.

Signal FocusGovernance

Neuralink conducts second brain chip implant trial has public-source relevance to network operations, governance, dependency mapping, or market structure.

Content TypePROFILE

Neuralink conducts second brain chip implant trial is tracked as a internet infrastructure institution within the internet infrastructure ecosystem.

Primary DomainGovernance

Public-source signals support medium-impact monitoring for infrastructure visibility and dependency analysis.

ImpactMedium

Public-source signals support medium-impact monitoring for infrastructure visibility and dependency analysis.

Confidence?Confidence Grade
0.90–1.00AHigh — direct sources
0.75–0.89A/BStrong
0.55–0.74B/CMedium
0.35–0.54C/DWeak–medium
0.10–0.34DWeak signal
0.00–0.09DInternal monitoring
Limited confidence (80%)

Several public sources

  • Neuralink 成功为第二名瘫痪患者植入脑芯片,使其能够通过意念控制数字设备,并计划今年再为八名患者植入。
  • 随着信号监测技术的改进,该脑芯片的意念控制光标速度创下了新的世界纪录。

我们的观点
Neuralink脑芯片植入的成功是增强瘫痪患者独立性的一项突破。然而,这些植入物的长期有效性和安全性对其广泛采用至关重要。
-Olivia FANG, BTW 记者
另见: FCC 以许可限制支持光纤建设者.

事件经过

在上周五发布的一次广播中,埃隆·马斯克宣布其初创公司Neuralink成功完成了对第二名脊髓损伤患者的脑芯片植入试验。马斯克对该植入物的性能表示乐观,指出第二名患者目前的1024个电极中有400个有效工作。 另见: Ofcom 揭露英国铁路移动覆盖差距.

第一位患者诺兰·阿博于今年一月接受了植入手术,他也参加了此次广播分享自己的经历。手术前,他只能用嘴叼着一根棍子来操作电脑,这种方法非常困难,极大地限制了他的独立性。但现在,他只需通过意念就能在电脑屏幕上移动光标来控制设备。 另见: 罗伯特·纽沃斯.

Neuralink计划今年继续临床试验,为另外八名患者植入脑芯片。 另见: 欧盟重写人工智能基础设施主权规则.

另请阅读:https://btw.media/en/newstop-tech-news-stories-today-august-2-2024/

另请阅读:https://btw.media/en/tech-trendsneuralinks-first-in-human-brain-implant-has-a-problem/

为何重要

Neuralink的这一最新进展的重要性怎么强调都不为过,因为它代表着针对严重行动障碍者的医疗技术可能发生革命。脑芯片植入有潜力帮助瘫痪人士重获一定程度的独立性,从而显著提高他们的生活质量。 另见: 欧盟限制美国卫星运营商接入频谱.

诺兰·阿博的经历有力支持了这一潜力。有了植入物,阿博可以仅凭意念控制电脑,大大减少了对护理人员的依赖,并获得了更多自主权。 另见: FCC 要求美国海底电缆登陆须获许可.

考虑到最初的技术挑战,这一进展更为了不起。手术后,阿博遇到了植入物的微小导线回缩的问题,导致能够测量大脑信号的电极数量急剧减少。Neuralink通过修改算法使其更加灵敏,从而恢复了植入物的功能。脑芯片的意念控制光标速度甚至创下了新的世界纪录。 另见: 美国封堵海外AI芯片采购漏洞.

在广播中,马斯克还讨论了监管效率的问题。通过倡导减少商业监管,他旨在加速能够改变生活的技术进步。 另见: Dish 违约后 FCC 重启 AWS-3 拍卖.

Domain of operation

Neuralink conducts second brain chip implant trial is profiled by BTW Media because published evidence links it to internet infrastructure, governance, operational dependencies, or market visibility.

  • Public role: Neuralink conducts second brain chip implant trial is framed by neuralink conducts second brain chip implant trial is tracked as a internet infrastructure institution within the internet infrastructure ecosystem. and public governance context. Evidence basis: Neuralink conducts second brain chip implant trial article record; Neuralink conducts second brain chip implant trial article record
  • Operating surface: Governance and Global provide the public context for this institution profile. Evidence basis: Neuralink conducts second brain chip implant trial article record; Neuralink conducts second brain chip implant trial article record

Timeline

  1. Neuralink conducts second brain chip implant trial public profile updated

    Public coverage records Neuralink conducts second brain chip implant trial as a subject for role, operating context, and evidence review.

At A Glance

  • Name: Neuralink conducts second brain chip implant trial
  • Type: Internet infrastructure institution
  • Base: Global
  • Profile focus: Institution

What It Does

  • Public records support monitoring of its role, services, and key relationships.

Why It Matters

  • Public-source signals support medium-impact monitoring for infrastructure visibility and dependency analysis.
  • Operational criticality: Medium
  • Time horizon: Next quarter

What To Watch

  • Monitoring focuses on verified service continuity, governance changes, and relationship signals.
NowMedium priority

Track verified source updates, role changes, and current public evidence.

QuarterMedium policy sensitivity

Public-source signals support medium-impact monitoring for infrastructure visibility and dependency analysis.

YearNext quarter outlook

Longer-term relevance depends on verified operating, policy, and relationship changes.

Member Briefing

Deeper Profile Context

Login is required to unlock the full profile briefing and source notes.

Only for Strategy Circle

Strategic Circle Access

Open to all readers. Unlock profile briefings after joining and logging in.

Join Strategic Circle

Only for Leadership Alliance

Leadership Alliance Access

For owners and management of IP-holding companies. Login required to unlock.

Join Leadership Alliance

Public View

The public read of Neuralink conducts second brain chip implant trial is limited to visible role, operating context, and relationship evidence.

Watchpoints

  • New public role, affiliation, product, policy, or market disclosures.
  • Verified relationship changes involving named organizations or people.

Caveats

  • Private or unverified claims are excluded from this public view.

FAQ

Why is Neuralink conducts second brain chip implant trial included?

Neuralink conducts second brain chip implant trial has public evidence that makes the institution relevant to BTW's coverage of digital infrastructure, governance, or markets.

What is public about this profile?

The public layer covers visible role, operating context, linked organizations, and evidence-backed watchpoints.

What should readers watch next?

Readers should watch for source-backed role changes, new partnerships, regulatory exposure, operating expansion, or evidence that changes the public assessment.

← BackAll Companies